Additional clarification on the value setting of the supply

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Additional clarification on the value setting of the supply activity transferred by AB Lietuvos Dujos

Vilnius, Lithuania, 2014-10-09 08:44 CEST (GLOBE NEWSWIRE) -- In response to inquiries of market participants, AB Lietuvos Dujos (hereinafter - the Company) announces that the value of the natural gas supply activity to be transferred to UAB Lietuvos Duju Tiekimas with all the assets, rights and obligations attributed thereto (hereinafter - Part of Enterprise) was set based on forecasted results, market trends affecting this activity and the scope of assets and obligations to be transferred by this transaction rather than on historical indicators, which, upon changed market situation, would lead to inadequate conclusions.  

Summary of evaluation assumptions of the Part of Enterprise

Gas volumes 

Gas volumes sold are significantly decreasing in non-household customer sector due to the activities of the Liquefied Natural Gas Terminal, development of renewable energy sources and increasing competition in the supply market, which will lead to a respective decrease of revenues from the supply activity. 

Retrospective discount 

On 7 May 2014 Company entered into an agreement with the supplier of natural gas OAO Gazprom regarding a significant reduction in the price of natural gas imported by AB Lietuvos Dujos for the period from 1 January 2013 till 31 December 2015, according to which the formula of imported natural gas price for the Company was adjusted retrospectively for the period from 1 January 2013 till 31 March 2014.

This effect of the decrease of natural gas price temporarily improved the financial results of Half 1 of 2014. However, the price reduction effect does not essentially increase the value of the supply activity, because it is assumed that decisions on reducing natural gas prices to consumers in the future will be made.

The above mentioned retrospective effect of the reduction of import price in the sense of cash flows will be fully reached by the end of 2014. The assumption was also made, that received cash flows will be used for reducing customer prices during the period till the end of 2016. 

Margins 

It is estimated that supply activity segment to be sold will remain competitive in 2015 – 2016, applying usual sales margins for both household and non-household customers. However, starting from 2017, upon the end of the planned period for using the effect of the reduction of price, sales margins will decrease in non-household customer segment due to the planned sharp competition.  Intense competition in the household customer segment is not planned due to high administrative costs. Therefore, sales margin in household consumer segment is forecasted to decrease only slightly.

Business value 

When calculating the supply segment value, two cash flow scenarios were forecasted and two value components were determined: 1) regular supply activity value without a retrospective natural gas import price reduction effect; 2) the value of natural gas price reduction effect and the use thereof.  

Having assessed market indicators and added a respective risk premium, the set WACC of the regular supply activity is equal to 11.69%.

The cash flow from the natural gas price reduction effect and the use thereof is discounted at a risk-free short-term rate of return. This cash flow is evaluated separately from regular cash flows, since this is a one-time effect without an element of business risk. 

When calculating continuing business value, an assumption was made that in the long term, the supply activity segment and cash flow, normalized given the forecasted relevant market trends, will increase by 2.0%, This long-term growth rate includes both the increase of natural gas consumption with growing Lithuanian economy and a possible slight increase in margin.

Taking into consideration these assumptions, the price for the Part of Enterprise, determined in the draft sale-purchase agreement of the Part of Enterprise approved by the Board of Directors of the Company, is LTL 60 457 000 (sixty million four hundred fifty seven thousand litas) (EUR 17 509 557.46 (seventeen million five hundred and nine thousand five hundred fifty seven euro and forty six euro cents)). The ownership right to the Part of Enterprise shall transfer to UAB Lietuvos Duju Tiekimas on 31 October 2014. 

The price for the Part of Enterprise corresponds to the market value of the Part of Enterprise determined by independent property assessors (UAB FMI Orion Securities and UAB APUS TURTAS).

It should be noted that the Part of Enterprise to be sold comprises only the assets and obligations, which will be necessary in the performance of future supply activity, i.e. LTL 338.5 million and LTL 328.5 million, respectively. Balance book value of net assets (the book value of equity) of the Part of Enterprise to be sold was equal to LTL 10 million as at 31 July 2014, meanwhile the balance book value of net assets of the supply activity was LTL 111 million as at 31 December 2013. That way, the majority of value created by the supply activity before the sale of the Part of Enterprise stays with AB Lietuvos Dujos.

The transfer of the Part of Enterprise is performed pursuant to the Action Plan of the Unbundling of the Natural Gas Distribution and Supply Activities of the Company coordinated with the National Control Commission for Prices and Energy.

Authorised person: Jolita Butkienė Officer of Strategic Development Division Tel. +3705 236 01 35

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stephanie L. Beiermann Shines in HR Consulting Honors

Updated Category News Views 114

Celebrating a Star in Payroll Optimization Ah, the name Stephanie L. Beiermann’s been making the rounds lately, catching eyes with her lauded expertise in payroll optimization and human resources. This recognition doesn’t come out of thin air—no, it’s anchored on a solid foundation of over 25 years of cutting through the fluff to sharpen operational edges. We’re...

Continue Reading
AvidXchange Acquisition Faces Fairness Investigation

Updated Category News Views 317

Unpacking the AvidXchange Turmoil Staring at the ticker tape feels like watching a drama unfold, and today it's all about AvidXchange Holdings, Inc. (NASDAQ: AVDX). Levi & Korsinsky, LLP has launched an investigation into the fairness of its acquisition, and let me tell you, when the suits start poking around, it means someone smells a rat. The deal in question? A buyout...

Continue Reading
Snowhawk Enters Telarus as Digital Demand Gets Serious

Updated Category News Views 7

Telarus just pulled another serious capital partner into the room, and that matters more than the usual law-firm victory lap. Snowhawk Partners has invested in the technology services distributor alongside Columbia Capital, which remains a long-standing partner. Nobody disclosed a valuation, ownership percentage, financing mix, or closing date. Annoying? Sure. But the...

Continue Reading
Lecanemab Shines in 5-Year Alzheimer's Study at CTAD

Updated Category News Views 172

Latest Lecanemab Results Turn Heads at CTAD 2026 The whispers buzzing out of the CTAD 2026 conference are about something promising for those in the trenches of Alzheimer's research: lecanemab. Yep, it's a name that's been bandied about before, and this time it's the long-term data doing the talking. The five-year results from Eisai and Biogen's lecanemab study are...

Continue Reading
Giovanni Recalde Sues County After False Report

Updated Category News Views 215

Justice and Reputation: A Mix-Up Costs Big When the cops screw up, sometimes they really take the cake. That's what Giovanni Recalde learned, the hard way, when his name got tangled in a mess related to a gambling operation he wasn't even a part of. Prince William County police pasted his name into their daily incident report last year like it was no big deal. But it...

Continue Reading
Amdocs Faces a Storm: Investor Alert as Legal Probe Begins

Updated Category News Views 64

Amdocs' Recent Crisis: What Investors Need to Know Lately, it seems Amdocs Limited (NASDAQ: DOX) has found itself knee-deep in a situation that could make seasoned investors cringe. November shone some harsh light on the company's operations, a move that’s attracted attention from Schall, Brown & Schwartz LLP (“SBS”), a name not exactly foreign to shareholder...

Continue Reading
OREF Opens $185,000 Research Grant Funding Cycle Today

Updated Category News Views 66

A hundred grand aimed at better graft science is not pocket change, but it is not a finished clinical program either. That distinction matters with the Orthopaedic Research and Education Foundation's newly opened $185,000 grant cycle. This is targeted, early-to-midstream research support: the sort of money that can produce usable data, sharpen a clinical question, and...

Continue Reading
Armada Moves up as Key Player in US SI Exports

Updated Category News Views 207

Pioneering New Grounds in Intelligence Infrastructure Hell of a move by Armada, stepping into the limelight as a priority team leader in the U.S. SI Exports Program. The whole gig is under the Department of Commerce's belt, pushing the frontier of America's Super Intelligence (SI) technology to buddies across the globe. It's like watching the next big blockbuster unfold...

Continue Reading
Intel Faces Class Action Over Alleged Securities Fraud

Updated Category News Views 122

Intel's Legal Predicament: Decoding the Lawsuit Saddle up, folks, because Intel (NASDAQ: INTC) has found itself tangled in legal vines again. This ain't their first rodeo, and probably won't be their last. We're looking at a hefty class action lawsuit rallying on claims that Intel misled investors with optimistic yarns about their health. SBS Law, waving the litigation...

Continue Reading
Lake Ridge's Strong Quarter Meets a Book Value Hit

Updated Category News Views 26

An $8.25-per-share securities markdown is the splinter in an otherwise sturdy third-quarter report from Lake Ridge Bancorp. The bank earned $9.8 million, or $4.97 per common share, for the quarter ended September 30, 2026. That is up from $9.0 million, or $4.59 per share, in the prior quarter and $7.7 million, or $3.94 per share, a year earlier. Those are not flimsy...

Continue Reading

Top 5 Most Recently Viewed Articles

T-Mobile US: A Decade of Impressive Stock Growth Revealed

Updated Category News Views 142

T-Mobile US and Its Remarkable Growth Journey T-Mobile US (NASDAQ: TMUS) has shown exceptional growth over the last decade. With an annualized return rate of 20.05%, the company has outpaced the broader market by 8.22%. As of the latest information available, T-Mobile's market capitalization stands at an impressive $269.40 billion, highlighting its substantial position...

Continue Reading
Analysts Adjust TFI International's Forecasts After Q3 Report

Updated Category News Views 67

TFI International Reports Weaker-Than-Expected Q3 Earnings After the market closed on a recent Monday, TFI International (NYSE: TFII) announced its quarterly earnings figures, which unfortunately fell below expectations. The company reported earnings of $1.60 per share, compared to analyst predictions of $1.78 per share. In addition, TFI International's quarterly revenue...

Continue Reading
C3.ai Investors Face Class Action Amidst Poor Financial Results

Updated Category News Views 179

C3.ai Class Action Overview The Portnoy Law Firm is stepping forward to represent investors of C3.ai, Inc. as a class action develops. This legal move comes after concerning preliminary financial results announced by the company. Investors who purchased securities of C3 during the specified class period are encouraged to engage with the firm. Details of the Legal Class...

Continue Reading
21st.BIO Seeks EU Nod for Precision Fermentation Tech

Updated Category News Views 172

Is Precision Fermentation Europe's Next Big Bet? Here we go again with another tech trying to revolutionize the food industry, and this time it's the Danish company 21st.BIO making strides in Europe. They've tossed their hat in the ring with an EU Novel Food application for BLG Essential+™, hoping to weave precision fermentation into the fabric of European food...

Continue Reading
Key Pfizer Executives Support Current Leadership Amid Challenges

Updated Category News Views 105

Support for Pfizer's Leadership from Former Executives In a recent statement, former Pfizer executives, Ian Read and Frank D'Amelio, clarified their stance regarding the ongoing campaign by activist investor Starboard Value. They emphasized that they will not be engaging with Starboard, which has been advocating for changes within the pharmaceutical giant to enhance its...

Continue Reading